These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 311530)

  • 41. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of the effect of modification of the surface of human platelets on the receptors for aggregated immunoglobulins and for ristocentin-von Willebrand factor.
    Pfueller SL; Jenkins CS; Lüscher EF
    Biochim Biophys Acta; 1977 Mar; 465(3):614-26. PubMed ID: 319830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.
    Brinkhous KM; Read MS; Reddick RL; Griggs TR
    Ann N Y Acad Sci; 1981; 370():191-204. PubMed ID: 7023318
    [No Abstract]   [Full Text] [Related]  

  • 45. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Von Willebrand factor has more than one binding site for platelets.
    Nokes TJ; Mahmoud NA; Savidge GF; Goodall AH; Meyer D; Edgington TS; Hardisty RM
    Thromb Res; 1984 Jun; 34(5):361-6. PubMed ID: 6610952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets.
    Moake JL; Olson JD; Troll JH; Tang SS; Funicella T; Peterson DM
    Thromb Res; 1980 Jul 1-15; 19(1-2):21-7. PubMed ID: 6969462
    [No Abstract]   [Full Text] [Related]  

  • 50. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jul 1-15; 19(1-2):287-92. PubMed ID: 6969463
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: A method for assaying von Willebrand factor (ristocetin cofactor).
    Macfarlane DE; Stibbe J; Kirby EP; Zucker MB; Grant RA; McPherson J
    Thromb Diath Haemorrh; 1975 Sep; 34(1):306-8. PubMed ID: 1081281
    [No Abstract]   [Full Text] [Related]  

  • 53. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 54. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proceedings: Relationship between factor VIII and von Willebrand's factor in plasma and serum.
    Koutts J; Gude N; Firkin B
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081756
    [No Abstract]   [Full Text] [Related]  

  • 56. Vancomycin effect on thrombin-induced platelet aggregation: evidence against a common platelet membrane receptor for thrombin and ristocetin.
    Weinger RS; Moake JL
    Thromb Res; 1978 May; 12(5):911-15. PubMed ID: 307833
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
    Hillarp A; Friedman KD; Adcock-Funk D; Tiefenbacher S; Nichols WL; Chen D; Stadler M; Schwartz BA
    Haemophilia; 2015 Nov; 21(6):837-45. PubMed ID: 26172561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding of porcine von Willebrand factor to human platelets in the presence of ristocetin.
    Silber P; Finlay TH
    Thromb Res; 1982 Jun; 26(5):351-8. PubMed ID: 7164028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybridoma antibodies to human von Willebrand factor. II. Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium.
    Meyer D; Baumgartner HR; Edginton TS
    Br J Haematol; 1984 Aug; 57(4):609-20. PubMed ID: 6204681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.